Celldex Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $16M | 376k | 41.97 |
| 2023-09-30 | $14M | 524k | 27.50 |
| 2023-06-30 | $4.7M | 138k | 34.00 |
| 2022-12-31 | $9.1M | 204k | 44.57 |
| 2022-06-30 | $12M | 482k | 25.81 |
| 2022-03-31 | $35M | 1.0M | 34.06 |
| 2021-06-30 | $0 | 123k | 0.00 |
| 2020-12-31 | $343k | 20k | 17.53 |
| 2020-09-30 | $244k | 16k | 15.34 |
| 2020-06-30 | $302k | 23k | 13.06 |
| 2020-03-31 | $33k | 20k | 1.68 |
| 2019-12-31 | $48k | 21k | 2.26 |
| 2019-09-30 | $20k | 9.4k | 2.10 |
| 2019-03-31 | $11k | 2.4k | 4.61 |